A Phase 1b/2a, Multicentre, Randomised, Double-Blind, Parralel-Group, Placebo Controlled Study to Evaluate the Safety & Pharmacokinetics of Z-360 in Subjects with Unreasonable Advanced Pancreatic Cancer in Combination with Gemcitabine....

  • Palmer, Daniel (Principal Investigator)

Project Details

Short titleA Phase 1b/2a, Multicentre, Randomised, Double-Blind, Parralel-Group, Placebo Controlled Study to Evaluate the Safety & Pharmacokinetics of Z-360 in Subjects with Unreasonable Advanced Pancreatic Cancer in Combination with Gemcitabine....
StatusFinished
Effective start/end date1/01/06 → 30/06/10

Funding

  • Queen Elizabeth Hospital Birmingham